CD4 and duodenal ulcer: Consistent with our results, omeprazole treatment increases the frequency of CD4+ CD25+ FoxP3+ Treg cells and decreases the frequency of CD4+ IL-17A+ T cells among peripheral blood mononuclear cells (PBMCs) of patients with duodenal ulcers.